The EORTC and SWOG trials treated patients with 2D treatment planning techniques where the prostatic fossa was targeted using large treatment portals in which precise definitions of target volumes ...

and 9% had disease localized only to the prostate fossa. Detection rates varied by initial treatment type. For example, among patients who had undergone radical prostatectomy alone, 34% had ...

of SBRT and a [short course of ADT] compared with SBRT alone in metachronous oligorecurrent hormone-sensitive prostate cancer ...